Bispecific Antibody
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
32
NCT07083960
OM336 in Autoimmune Cytopenias
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 1, 2025
Completion: Sep 30, 2027
Loading map...